Valaenza Pharmaceuticals Private Limited, a active private limited company, was established on 27 July 2011 in Daskroi, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24239GJ2011PTC066549. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.20 M and a paid-up capital of ₹5.20 M.
It upholds a compliant status. Its leadership includes Akash Hasmukhbhai Patel (Director), Shaunak Prashantbhai Shah (Director), Gunjan Kamlesh Amin (Director). Past directors included Pankaj Shantilal Shah, Akash Hasmukhbhai Patel, Hardik Harshadbhai Thakkar. It holds ₹1.20 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 2215-2216, Radha Krushna Estate, Near Darshan Hotel, Aslali, Ahmedabad, Daskroi, Gujarat, 382427.
U24239GJ2011PTC066549
066549
27 July 2011
₹5.20 M
₹5.20 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Valaenza Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Akash Hasmukhbhai Patel | Director | 02 Feb 2019 | Current |
| Shaunak Prashantbhai Shah | Director | 27 Jul 2011 | Current |
| Gunjan Kamlesh Amin | Director | 24 Oct 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Jun 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 30 Oct 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Valaenza Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 18.19% decrease. The company also saw a substantial fall in profitability, with a 47.98% decrease in profit. The company's net worth moved up by a moderate rise of 3.4%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Valaenza Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹12,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Oct 2024 | Hdfc Bank Limited | ₹9.00 M | Open |
| 06 Dec 2022 | Others | ₹3.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Valaenza Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Valaenza Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Valaenza Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Valaenza Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Valaenza Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 9.00 M with Charge ID 101002336 was registered on 30 Oct 2024. was completed.
The activity A charge with Others amounted to Rs. 3.00 M with Charge ID 100656404 was registered on 06 Dec 2022. was completed.
The activity Akash Hasmukhbhai Patel was appointed as a Director was appointed as a Director on 02 Feb 2019 & has been associated with this company since 6 years 10 months . was completed.
The activity Gunjan Kamlesh Amin was appointed as a Director was appointed as a Director on 24 Oct 2011 & has been associated with this company since 14 years 1 month . was completed.
The CIN of Valaenza Pharmaceuticals Private Limited is U24239GJ2011PTC066549.
Valaenza Pharmaceuticals Private Limited is headquartered at 2215-2216, Radha Krushna Estate, Near Darshan Hotel, Aslali, Ahmedabad, Daskroi, Gujarat, 382427.
Valaenza Pharmaceuticals Private Limited was incorporated on 27 July 2011.
The current directors of Valaenza Pharmaceuticals Private Limited are
The primary industry of Valaenza Pharmaceuticals Private Limited is Manufacturing.
Valaenza Pharmaceuticals Private Limited is unlisted.
The authorized capital of Valaenza Pharmaceuticals Private Limited is ₹5.20 M, and the paid-up capital is ₹5.20 M.
The compliance status of Valaenza Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX